Get Your Personalized Supplement StackSupplement Stack Quiz

Boswellia extract

Also known as: Boswellia serrata, Boswellia carterii, Boswellia sacra, Indian frankincense, Salai guggal

Overview

Boswellia extract is derived from the resin of Boswellia trees, primarily Boswellia serrata, and has been a staple in traditional Ayurvedic medicine for centuries due to its anti-inflammatory properties. The extract's therapeutic effects are attributed to its active compounds, boswellic acids, which include key molecules like 11-keto-β-boswellic acid and acetyl-11-keto-β-boswellic acid. It is widely recognized for its application in managing inflammatory conditions, particularly osteoarthritis, where it helps alleviate pain and improve physical function. Emerging research also suggests its potential benefits in metabolic disorders such as type 2 diabetes mellitus. While research on Boswellia is moderately mature, with several randomized controlled trials and meta-analyses supporting its efficacy, especially for musculoskeletal and inflammatory conditions, the quality of evidence can vary, with some studies presenting methodological limitations. It is available as a dietary supplement, often in capsule or tablet form, and is increasingly combined with other anti-inflammatory agents for enhanced effects.

Benefits

Boswellia extract offers several evidence-based benefits, primarily as an anti-inflammatory agent. For osteoarthritis (OA), it significantly reduces pain, stiffness, and improves physical function. A 2020 systematic review and meta-analysis of randomized controlled trials (RCTs) found significant improvements in WOMAC scores (a measure of OA symptoms) with recommended doses of 100–250 mg daily over 4 weeks or more, indicating a moderate effect size. In inflammatory conditions like ankylosing spondylitis, a 2025 RCT demonstrated that full-spectrum Boswellia serrata extract (F-BSE) and a combined Boswellia-curcumin complex (C-BSE) significantly reduced pain and stiffness within 14 days, with the combined formulation showing superior efficacy, suggesting synergistic anti-inflammatory effects. Beyond inflammation, a 2024 systematic review and meta-analysis reported that Boswellia supplementation improved glycemic markers, specifically HbA1c, and lipid profiles (reducing total cholesterol, triglycerides, and LDL) in patients with type 2 diabetes mellitus, indicating potential benefits in metabolic syndrome management. These metabolic improvements, while statistically significant for HbA1c, suggest a clinically meaningful impact on glycemic control. Benefits in pain and stiffness typically appear within two weeks of consistent supplementation, while metabolic effects may require longer durations.

How it works

Boswellia's primary mechanism of action involves the inhibition of 5-lipoxygenase (5-LOX) by its active compounds, boswellic acids. This inhibition reduces the synthesis of leukotrienes, which are potent mediators of inflammation. Beyond 5-LOX inhibition, boswellic acids also modulate various inflammatory cytokines, such as IL-1β, and interfere with the activity of the NLRP3 inflammasome, further contributing to reduced inflammation and pain. The extract influences multiple inflammatory pathways, including the crucial NF-κB signaling pathway, which plays a central role in immune and inflammatory responses. While the absorption of boswellic acids is naturally limited due to their lipophilic nature, modern formulation technologies, such as water-soluble complexes, are employed to enhance their bioavailability and improve therapeutic efficacy.

Side effects

Boswellia extract is generally considered safe, with a low incidence of adverse effects reported in clinical trials. The most common side effects, occurring in over 5% of users, are mild gastrointestinal discomfort and nausea. Less common side effects, affecting 1-5% of individuals, include allergic reactions and skin rash. Serious adverse events are rare, with no significant concerns reported in high-quality studies. Data on drug interactions are limited, but caution is advised when combining Boswellia with anticoagulants or other anti-inflammatory drugs due to the potential for additive effects. Contraindications include a known allergy to Boswellia or frankincense. The safety of Boswellia during pregnancy and lactation has not been well established, and its use in these populations is not recommended without medical supervision. Overall, its safety profile is favorable, but users should be aware of potential mild digestive issues.

Dosage

The recommended dosage of Boswellia extract varies depending on the condition and formulation, but generally, the minimum effective dose is around 100 mg/day of standardized boswellic acids. For osteoarthritis, an optimal dosage range is typically 100–250 mg/day. For more acute inflammatory conditions or in combination formulations, dosages can go up to 400 mg/day. The maximum safe dose is not definitively established, but most studies have used up to 400 mg/day without reporting serious adverse effects. Benefits, particularly for pain and stiffness, can be observed within two weeks of consistent daily dosing, and continuous supplementation is recommended for sustained effects. The form of the extract is crucial; full-spectrum extracts and formulations designed for enhanced bioavailability, such as those utilizing FenuMat® technology, can improve efficacy. Due to the lipophilic nature of boswellic acids, formulations that enhance solubility are preferred to improve absorption. Boswellia is often combined with other anti-inflammatory agents like curcumin to achieve synergistic effects.

FAQs

Is Boswellia extract safe long-term?

Current evidence supports safety for up to 4–8 weeks of use. Longer-term studies are limited, so consult a healthcare professional for extended use.

How soon will I see effects?

Improvements in pain and stiffness can typically be observed within two weeks of consistent daily supplementation.

Can Boswellia replace NSAIDs?

Boswellia may help reduce reliance on NSAIDs due to its anti-inflammatory properties, but it should not replace prescribed treatments without medical advice.

Does Boswellia help with diabetes?

Emerging research suggests Boswellia may improve glycemic control (HbA1c) and lipid profiles in type 2 diabetes, but more extensive research is needed.

Are all Boswellia extracts equal?

No, the efficacy of Boswellia extracts can vary significantly based on standardization of active compounds (boswellic acids) and bioavailability-enhancing formulations.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC7368679/ – This systematic review and meta-analysis found that Boswellia extract significantly improved osteoarthritis symptoms (pain, stiffness, function) compared to placebo. It suggested a recommended dose of 100–250 mg/day for at least 4 weeks, noting moderate heterogeneity among studies and some with medium to high risk of bias.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1577429/full – This double-blind, placebo-controlled RCT involving 105 participants demonstrated that both full-spectrum Boswellia and a Boswellia-curcumin complex significantly reduced pain and stiffness in ankylosing spondylitis patients. The combined extract showed superior efficacy, indicating synergistic anti-inflammatory effects within 28 days.
https://www.frontiersin.org/journals/clinical-diabetes-and-healthcare/articles/10.3389/fcdhc.2024.1466408/full – This systematic review and meta-analysis indicated that Boswellia supplementation improved HbA1c, total cholesterol, triglycerides, and LDL levels in patients with type 2 diabetes. While fasting blood glucose improvements were not statistically significant, the findings suggest potential benefits for metabolic syndrome management, though some included studies had a risk of bias.
https://pubmed.ncbi.nlm.nih.gov/32680575/ – This publication, likely the same as the first source, reinforces that Boswellia serrata extract is effective in improving symptoms of osteoarthritis, including pain, stiffness, and physical function, based on a meta-analysis of randomized controlled trials. It supports the use of Boswellia as a complementary therapy for OA.